Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni L Ripley

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The Annals of Pharmacotherapy|February 3, 2005
Valsartan in chronic heart failureToni L Ripley
Expert Opinion on Drug Safety|August 11, 2007
Side effects of using nitrates to treat heart failure and the acute coronary syndromes, unstable angina and acute myocardial infarctionUdho Thadani, Toni L Ripley
Journal of Managed Care & Specialty Pharmacy|January 24, 2015
Sorting it out: what JNC 8 is and what it is notShannon Finks, Toni L Ripley
Journal of Pharmacy Practice|December 16, 2015
Controversies Among the Hypertension GuidelinesToni L Ripley, Mary Baumert
Lancet (London, England)|September 2, 2008
The power to TRANSCENDToni L Ripley, Donald Harrison
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 14, 2009
Anticoagulation in patients with heart failure and normal sinus rhythmToni L Ripley, Edith Nutescu
The Annals of Pharmacotherapy|April 2, 2014
β-blockers: a review of their pharmacological and physiological diversity in hypertensionToni L Ripley, Joseph J Saseen
Current Heart Failure Reports|December 4, 2010
Controversies in cardiac resynchronization therapy: do sex differences in response exist?Robin E Germany, Toni L Ripley
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 24, 2005
Aldosterone antagonists in the treatment of heart failureTodd R Marcy, Toni L Ripley
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|October 19, 2011
The beers criteria as an outpatient screening tool for potentially inappropriate medicationsRebecca L Dunn, Donald Harrison, Toni L Ripley
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Annals of Pharmacotherapy|February 3, 2005
Valsartan in chronic heart failureToni L Ripley
Expert Opinion on Drug Safety|August 11, 2007
Side effects of using nitrates to treat heart failure and the acute coronary syndromes, unstable angina and acute myocardial infarctionUdho Thadani, Toni L Ripley
Journal of Managed Care & Specialty Pharmacy|January 24, 2015
Sorting it out: what JNC 8 is and what it is notShannon Finks, Toni L Ripley
Journal of Pharmacy Practice|December 16, 2015
Controversies Among the Hypertension GuidelinesToni L Ripley, Mary Baumert
Lancet (London, England)|September 2, 2008
The power to TRANSCENDToni L Ripley, Donald Harrison
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 14, 2009
Anticoagulation in patients with heart failure and normal sinus rhythmToni L Ripley, Edith Nutescu
The Annals of Pharmacotherapy|April 2, 2014
β-blockers: a review of their pharmacological and physiological diversity in hypertensionToni L Ripley, Joseph J Saseen
Current Heart Failure Reports|December 4, 2010
Controversies in cardiac resynchronization therapy: do sex differences in response exist?Robin E Germany, Toni L Ripley
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 24, 2005
Aldosterone antagonists in the treatment of heart failureTodd R Marcy, Toni L Ripley
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|October 19, 2011
The beers criteria as an outpatient screening tool for potentially inappropriate medicationsRebecca L Dunn, Donald Harrison, Toni L Ripley
Pageof 3